Abstract
ONE of the transplantable tumours widely used in investigations of tumour immunology is Sarcoma I (SaI), a tumour that originated in 1947 in a mouse of the Strong A strain that had been treated with dibenzanthracene1. We, as well as others, have maintained the tumour by transplantation in mice of the A/Jax strain, a sub-line of the Strong A strain, and utilize animals of this strain as the susceptible host in various experiments. Since any immunological response, even though it may be insufficient to cause rejection of the tumour, may influence the results of experiments with this tumour-host system, it appeared desirable to determine whether an immunological response to SaI occurs in the A/Jax mouse. From work of others it appeared that the possibility of an antigenic disparity between the tumour and the A/Jax mouse is favoured by the likelihood of genetic change in the mouse or the tumour during the prolonged period of transplantation and by the fact that the tumour was induced by dibenzanthracene2,3.
Similar content being viewed by others
Article PDF
References
Lucké, B., J. Nat. Cancer Inst., 13, 1299 (1953).
Prehn, R. T., and Main, J. M., J. Nat. Cancer Inst., 18, 769 (1957).
Klein, G., Sjogren, O., Klein, E., and Hellstrom, K. E., Cancer Res., 20, 1561 (1960).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
JUTILA, J., WEISER, R. & EVANS, C. Immunization of the A/Jax Mouse with Irradiated Cells of its Indigenous Tumour, Sarcoma I. Nature 195, 301 (1962). https://doi.org/10.1038/195301a0
Issue Date:
DOI: https://doi.org/10.1038/195301a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.